Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Synopsys Sees Q4 Adj. EPS $3.27-$3.32 vs $3.23 Est., Revenue 1.614B-$1.644B vs $1.61B Est.; Sees FY24 Adj. EPS $13.07-$13.12 vs $13.08 Est., Revenue $6.105B-$6.135B vs $6.13B Est.

Author: Benzinga Newsdesk | August 21, 2024 04:40pm

Posted In: SNPS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist